EILEEN TEYIM: Open Payments
NPI 1770767014 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,902 in 143 payments from 17 companies in 2025. Trend: 2023 $2,120 · 2024 $2,257 · 2025 $2,902
Food & beverage: $2,759Education: $143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $510 |
| Vanda Pharmaceuticals Inc. | 22 | $490 |
| Otsuka America Pharmaceutical, Inc. | 18 | $369 |
| Teva Pharmaceuticals USA, Inc. | 11 | $238 |
| Collegium Pharmaceutical, Inc. | 11 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $189 |
| Lundbeck LLC | 9 | $163 |
| E.R. Squibb & Sons, L.L.C. | 8 | $150 |
| Tris Pharma Inc | 4 | $94 |
Products named: VRAYLAR, FANAPT, REXULTI, Jornay PM, CAPLYTA, TRINTELLIX, COBENFY, UZEDY.
Industry payments across PA — which companies pay providers there.
